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The biocompatibility of peptide-based hydrogels make them ideal for biomedical applications such as 
drug delivery, biosensing, tissue engineering and wound healing [1-3]. However, the enzymatic 
hydrolysis of these materials can be regarded as a serious disadvantage. One way to increase the 
biostability of this type of hydrogels consists in using non-proteinogenic amino acids. In this work, 
several new hydrogelators were developed, containing a Naproxen or a Naphthalene group (Table 1), 
and their critical aggregation concentrations were determined by fluorescence. The influence of pH in 
the aggregation of these molecules was also investigated. TEM images revealed that these hydrogels 
contain entangled nanofibers with width ranging from 9 nm to 18 nm (Figure 1). 
The ability of these hydrogels to act as nanocarriers for an antitumoral drug was investigated. For that 
purpose, FRET (Förster Resonance Energy Transfer) assays were performed between the several 
hydrogels (acting as energy donors) and the new antitumoral fluorescent thieno[3,2-b]pyridine derivative 
1 [4] (acting as energy acceptor). Donor-acceptor distances between 2.5nm and 3.5nm were 
determined. 
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Antitumoral 
thieno[3,2-b]pyridine derivative 1 
The interaction between the new hydrogels and models of biological membranes was also confirmed by 
FRET. Lipid vesicles composed of egg lecithin/cholesterol 7:3 were used as membrane models, 
containing both the antitumoral compound 1 (as energy donor) and the lipid probe Nile Red (as energy 
acceptor). In this system, efficient energy transfer is observed. Upon interaction with the several 
hydrogelators, FRET vanishes, indicating a strong increase of the donor-acceptor distance.  
As the antitumoral compound tested here is especially active against human melanoma cell lines (GI50= 
=3.5 µM) [4], the results obtained here confirm the ability of these hydrogels to act as drug nanocarriers, 
being promising to the development of formulations for topical application. 
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Table 1. Structure of the several hydrogelators 
Hydrogelator Structure Hydrogelator Structure 
Npx-Phe-ΔPhe-OH 
 
1-Naph-Phe-ΔPhe-OH 
 
Npx-Phe-ΔAbu-OH 
 
2-Naph-Phe-ΔPhe-OH 
 
Npx-Trp-ΔPhe-OH 
 
Npx: Naproxen 
Phe: Phenylalanine 
Abu: Aminobutyric acid 
Trp: Tryptophan 
Naph: Naphthalene 
 
Figure 1. TEM images of Npx-Phe-ΔPhe-OH (A) and Npx-Phe-ΔAbu-OH (B). 
 
Figure 2. Normalized emission spectra of Naproxen hydrogels in the presence of compound 1, exciting 
the hydrogels (exc=290 nm) and exciting only compound 1 (exc=360nm). 
